- Australia’s Origin Energy Ltd (OTC:OGFGY) (OTC:OGFGF) bagged a takeover proposal worth around $10 billion from a consortium led by Brookfield Asset Management Inc. (NYSE:BAM).
- Origin said the consortium comprising Brookfield and the LNG arm of private-equity firm EIG had indicated it would make a cash offer at 9 Australian dollars a share, equivalent to $5.79.
- Origin said its board plans to recommend that shareholders vote in favor of a deal if the consortium makes a formal bid after completing due diligence and in the absence of a superior proposal.
- The consortium’s latest offer follows two earlier proposals.
- Origin is a significant shareholder in the Australia Pacific LNG plant in eastern Australia’s Queensland state, which supplies liquefied natural gas to Asia, the Wall Street Journal reports.
- The ConocoPhillips (NYSE:COP) operated facility has benefited from elevated LNG prices after Russia’s invasion of Ukraine, as European countries scour the world for alternative sources to Russian supply.
- The report added that Origin also owns power plants and is one of Australia’s most considerable electricity and gas retailers to households and businesses.
- The proposal would ultimately result in Brookfield acquiring Origin’s Energy Markets business and MidOcean buying the Integrated Gas business.
- Last year, Origin agreed to sell a 10% stake in the Australia Pacific LNG project to EIG for 2.12 billion Australian dollars. Still, the deal failed as ConocoPhillips exercised its pre-emption rights to acquire the interest instead.
- Analysts expect LNG prices to remain high for some time as Europe spends billions of dollars to wean itself off Russian gas, despite China’s economic weakness and potential for a global recession.
- Price Action: OGFGY shares closed 2.14%higher at $3.70 on Wednesday.
- Photo Via Company
Bright Green Announces Federal Registration And License Approval From The U.S. Drug Enforcement Administration Confirming Bright Green As A Bulk Manufacturer Of Cannabis
Bright Green is now the first publicly traded company, and the largest, in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical
